166 related articles for article (PubMed ID: 36394721)
1. Classification of Alzheimer's disease stage using machine learning for left and right oxygenation difference signals in the prefrontal cortex: a patient-level, single-group, diagnostic interventional trial.
Kim J; Kim SC; Kang D; Yon DK; Kim JG
Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):7734-7741. PubMed ID: 36394721
[TBL] [Abstract][Full Text] [Related]
2. Quantification of identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy with machine learning: a post hoc analysis of a diagnostic trial and validation of an external additional trial.
Kim J; Lee H; Lee J; Rhee SY; Shin JI; Lee SW; Cho W; Min C; Kwon R; Kim JG; Yon DK
Alzheimers Res Ther; 2023 Jul; 15(1):127. PubMed ID: 37481573
[TBL] [Abstract][Full Text] [Related]
3. Novel diagnostic tools for identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy: patient-level, single-group, diagnostic trial.
Kim J; Yon DK; Choi KY; Lee JJ; Kim N; Lee KH; Kim JG
Alzheimers Res Ther; 2022 Mar; 14(1):39. PubMed ID: 35260170
[TBL] [Abstract][Full Text] [Related]
4. Feature extraction of time series data on functional near-infrared spectroscopy and comparison of deep learning performance for classifying patients with Alzheimer's-related mild cognitive impairment: a post-hoc analysis of a diagnostic interventional trial.
Kim J; Kim SC; Kang D; Kim SY; Kwon R; Yon DK; Kim JG
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6824-6830. PubMed ID: 37522693
[TBL] [Abstract][Full Text] [Related]
5. Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach.
Li J; Bur AM; Villwock MR; Shankar S; Palmer G; Sykes KJ; Villwock JA
J Alzheimers Dis; 2021; 81(2):641-650. PubMed ID: 33843686
[TBL] [Abstract][Full Text] [Related]
6. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
[TBL] [Abstract][Full Text] [Related]
7. Deep Learning and Risk Score Classification of Mild Cognitive Impairment and Alzheimer's Disease.
Nagaraj S; Duong TQ
J Alzheimers Dis; 2021; 80(3):1079-1090. PubMed ID: 33646166
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
[TBL] [Abstract][Full Text] [Related]
9. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
[TBL] [Abstract][Full Text] [Related]
10. Comparison between the story recall test and the word-list learning test in Korean patients with mild cognitive impairment and early stage of Alzheimer's disease.
Baek MJ; Kim HJ; Kim S
J Clin Exp Neuropsychol; 2012; 34(4):396-404. PubMed ID: 22263656
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
[TBL] [Abstract][Full Text] [Related]
12. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
13. Short-Term Memory Binding Distinguishing Amnestic Mild Cognitive Impairment from Healthy Aging: A Machine Learning Study.
Martínez-Florez JF; Osorio JD; Cediel JC; Rivas JC; Granados-Sánchez AM; López-Peláez J; Jaramillo T; Cardona JF
J Alzheimers Dis; 2021; 81(2):729-742. PubMed ID: 33814438
[TBL] [Abstract][Full Text] [Related]
14. Verification of the association between cognitive decline and olfactory dysfunction using a DEmentia screening kit in subjects with Alzheimer's dementia, mild cognitive impairment, and normal cognitive function (DESK study): A multicenter, open-label, interventional study.
Fukumoto T; Ezaki T; Urakami K
eNeurologicalSci; 2022 Dec; 29():100439. PubMed ID: 36531966
[TBL] [Abstract][Full Text] [Related]
15. Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale Useful in Screening for Mild Cognitive Impairment and Alzheimer's Disease? A Systematic Review.
Park SH; Han KS
Curr Alzheimer Res; 2022; 19(3):202-211. PubMed ID: 35379127
[TBL] [Abstract][Full Text] [Related]
16. Automatic Detection of Cognitive Impairments through Acoustic Analysis of Speech.
Nagumo R; Zhang Y; Ogawa Y; Hosokawa M; Abe K; Ukeda T; Sumi S; Kurita S; Nakakubo S; Lee S; Doi T; Shimada H
Curr Alzheimer Res; 2020; 17(1):60-68. PubMed ID: 32053074
[TBL] [Abstract][Full Text] [Related]
17. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
[TBL] [Abstract][Full Text] [Related]
18. Validation study of the Alzheimer's disease assessment scale-cognitive subscale (ADAS-Cog) for the Portuguese patients with mild cognitive impairment and Alzheimer's disease.
Nogueira J; Freitas S; Duro D; Almeida J; Santana I
Clin Neuropsychol; 2018; 32(sup1):46-59. PubMed ID: 29566598
[TBL] [Abstract][Full Text] [Related]
19. Brief Test of Olfactory Dysfunction Based on Diagnostic Features of Specific Odors in Early-Stage Alzheimer Disease.
Audronyte E; Sutnikiene V; Pakulaite-Kazliene G; Kaubrys G
Med Sci Monit; 2023 May; 29():e940363. PubMed ID: 37243326
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
